Paclitaxel Injection
Product Images NDC 68001-705

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 68001-705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Paclitaxel Inj Carton (Image 01)

Paclitaxel Inj Carton (Image 01)
Packaging label for Paclitaxel Injection, USP 300 mg/50 mL (6 mg/mL) by BluePoint Laboratories, a semisynthetic cytotoxic agent. Label includes dilution warning, storage instructions, and manufacturer information (Alembic Pharmaceuticals Limited, India). Multi-dose vial, NDC 68001-705-27.*
FDA Label Image

Paclitaxel-1figure (Paclitaxel 1figure)

Paclitaxel-1figure (Paclitaxel 1figure)
A survival curve chart showing the proportion surviving over a period of 0 to 5 years. Two groups, labeled Cc and Tc, are compared with separate survival curves. The chart includes a table with sample sizes, number of events, and hazard ratio with confidence interval for the two groups, as well as the number at risk at various time points.*
FDA Label Image

Paclitaxel-2figure (Paclitaxel 2figure)

Paclitaxel-2figure (Paclitaxel 2figure)
A survival curve graph showing the proportion surviving over a period of 0 to 5 years. The graph compares two groups labeled 'Cc' and 'Tc', with additional info on sample sizes, number of events, hazard ratio, and confidence interval presented in a boxed inset. Number at risk data is displayed below the x-axis for both groups at different time points.*
FDA Label Image

Paclitaxel Inj Label (Paclitaxel 30mg Vial Label)

Paclitaxel Inj Label (Paclitaxel 30mg Vial Label)
Label for Paclitaxel Injection, USP 300 mg/50 mL (6 mg/mL) intravenous injection by BluePoint Laboratories. The label indicates a semisynthetic formulation in a 50 mL multiple dose vial with dilution required prior to intravenous infusion. It includes cautions about handling, storage between 20° to 25°C, and warnings about cytotoxicity. Manufacturer is Alembic Pharmaceuticals Limited, India.*
FDA Label Image

Paclitaxel-3figure (Paclitaxel 3figure)

Paclitaxel-3figure (Paclitaxel 3figure)
A Kaplan-Meier survival curve showing the proportion of patients disease-free over a 4-year period. The graph compares two treatment groups labeled AC and AC+T, with accompanying data on the number of patients at risk, number of events, and hazard ratio (HR) with 95% confidence interval (CI). The y-axis represents the proportion disease free, and the x-axis represents years.*
FDA Label Image

Paclitaxel-4figure (Paclitaxel 4figure)

Paclitaxel-4figure (Paclitaxel 4figure)
A survival curve chart showing the proportion surviving over a period of 4 years comparing two treatment groups labeled AC and AC+T. The chart includes a table with event numbers, hazard ratio, and confidence intervals, as well as the number at risk at various time points for each group.*
FDA Label Image

Paclitaxel-5figure (Paclitaxel 5figure)

Paclitaxel-5figure (Paclitaxel 5figure)
A Kaplan-Meier survival curve illustrating the proportion of subjects disease free over a 4-year period, comparing two treatment groups labeled AC and AC+T. The chart includes a data table with number of subjects (N), number of events, hazard ratio (HR) with 95% confidence interval (CI), and number at risk at various time points for both groups.*
FDA Label Image

Paclitaxel-6figure (Paclitaxel 6figure)

Paclitaxel-6figure (Paclitaxel 6figure)
A Kaplan-Meier survival curve graph showing the proportion disease free over a 4-year period for two groups labeled AC and AC+T. The graph includes the number of patients at risk at various time points and a table with total number of events, hazard ratio, and confidence interval for comparison between groups.*
FDA Label Image

Paclitaxel-7figure (Paclitaxel 7figure)

Paclitaxel-7figure (Paclitaxel 7figure)
A Kaplan-Meier survival curve chart showing the proportion of disease-free patients over a 4-year period, comparing two treatment groups labeled AC and AC+T. The chart includes numbers at risk and event totals for each group, with a hazard ratio and 95% confidence interval presented in an inset.*
FDA Label Image

Paclitaxel-8figure (Paclitaxel 8figure)

Paclitaxel-8figure (Paclitaxel 8figure)
A Kaplan-Meier curve comparing the proportion of patients disease free over time in years for two groups, AC and AC+T. The graph includes a table showing sample sizes, number of events, hazard ratio (HR), and confidence interval (CI). The x-axis represents years up to 4, and the y-axis shows the proportion disease free from 0 to 1.*
FDA Label Image

Paclitaxel-str (Paclitaxel Str)

Paclitaxel-str (Paclitaxel Str)
Chemical structure diagram of paclitaxel, the active ingredient shown with its molecular framework including phenyl, acetyl, and ester functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.